"There needs to be a culture of privacy and security, especially in healthcare," said Stephen Gillett, our Chairman and CEO, while on stage at Fortune Brainstorm Health with Bob Segert, Andrea Downing and moderator Andrew Nusca. Stephen also discussed lessons learned from the Change Healthcare breach, including the opportunities for partnerships between the public and private sectors. "Public private partnership will take average or below average security and make it good or great but don't try to do it all yourself."
This #ClinicalTrialsDay, we celebrate all that has been accomplished to advance medical research thanks to clinical trials and the people behind them. Through Verily Viewpoint, we support research sites and sponsors to make clinical trials more efficient and more representative. Our site clinical trial management system (CTMS) was purpose built for enterprise research sites, designed to digitize study protocols and eliminate siloed manual processes to enable more efficient research, higher-quality output and maximum research revenue. We are committed to supporting clinical trial innovation with these solutions. Thank you to all professionals and participants for your dedication to helping advance treatments and cures.
Building trust in communities that have been historically underrepresented in clinical studies is an important step to expanding diversity in clinical trials. Andrew Trister, MD PhD, our Chief Medical and Science Officer discussed strategies to make progress while at the recent Milken Institute Global Conference: “Clinical trials are more successful when participants feel like they’re centered in the process. One way to reflect this is in the language associated with clinical trial participation.” “Even the language that we use when we talk about clinical studies represents a change in the hierarchy and shifts how the trust relationship works — a person becomes a subject in a study as opposed to being a patient.”
Living with a disability can encompass a wide range of experiences. Building accessible and inclusive solutions requires us to consider these needs early in the product development lifecycle so that we build with and for everyone. At Verily, some of our best practices for diversity by design include: ▶ Accessibility and inclusion principles integrated throughout our product design system ▶ User research and focus groups with individuals from historically marginalized communities ▶ Internal awareness and education through our disability-focused employee resource group
Meet Stephen Gillett, Verily Chairman and CEO, at Fortune Brainstorm Health next Tuesday, May 21. He’ll join Bob Segert of athenahealth, Andrea Downing of The Light Collective, and moderator Andrew Nusca to discuss the growing threat of cybersecurity breaches in the healthcare industry and how to build a resilient health system and ensure patient trust.
Exciting news for the ALS research community! Target ALS has added comprehensive datasets from its Natural History Study to their data portal. The portal uses Verily Workbench, a collaborative research environment for governing and analyzing global multimodal data to fuel discovery of treatments and biomarkers for ALS.
Diabetes management is overwhelming and complex. We get it. Through data-driven in-app activities and dedicated care team support, Onduo, our virtual care solution, can support better diabetes self-management and lasting, healthier habits. It helps to make doing the right thing, the easy thing.
We are thrilled to see Dan Doctoroff,Target ALS Founder and Chairman, on the list of TIME100 Most Influential People in Health of 2024. Over the past decade, he has been dedicated to progressing ALS research and in 2021, after being diagnosed with ALS himself, Doctoroff made it his full-time focus. Target ALS uses Verily Workbench to securely access and analyze multimodal ALS data in order to better understand the disease and advance treatment. We are proud to partner with them on this important initiative.
When designing clinical trials, what does it mean to meet patients where they are? Andrew Trister, MD PhD, our Chief Medical and Science Officer, answered this question at the Milken Institute Global Conference, referencing the use of wearables and observational studies. "Collecting data outside the traditional confines of the clinical study or health system can be very helpful in determining how these drugs, devices and tools really do impact health." “This type of real-world data can be a huge augmentation to the way that we understand health and disease and the way that people are living.” Dr. Trister went on to talk about another layer of data, leveraging experience – “take what you learn from each patient and apply it to the next.”
Integrating data from many sources is critical to improve health outcomes research. At ISPORAnnual 2024, the plenary session featuring our Head of Strategic Affairs Joe Franklin focused on how we can address the complexities of data linkage and drive towards a common understanding of fit-for-purpose approaches for evidence generation. Our team also shared results from the Project Baseline Health Study, highlighting findings on remote participant engagement and the validity of remote screening for symptoms of depression.
